Short Interest in Hypermarcas (OTCMKTS:HYPMY) Decreases By 32.9%

Hypermarcas (OTCMKTS:HYPMY) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totaling 6,225 shares, a decline of 32.9% from the August 15th total of 9,271 shares. Based on an average daily trading volume, of 7,201 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.0% of the shares of the stock are sold short.

Hypermarcas Trading Down 0.9%

OTCMKTS HYPMY traded down $0.04 during trading on Thursday, hitting $4.50. The company had a trading volume of 3,599 shares, compared to its average volume of 4,942. The company has a market cap of $3.17 billion, a price-to-earnings ratio of 9.00 and a beta of 0.71. The company’s fifty day moving average is $4.20 and its 200-day moving average is $4.30. Hypermarcas has a one year low of $3.71 and a one year high of $5.50. The company has a current ratio of 1.86, a quick ratio of 1.26 and a debt-to-equity ratio of 0.50.

Hypermarcas (OTCMKTS:HYPMY) last issued its earnings results on Thursday, August 6th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 12.68%. On average, sell-side analysts predict that Hypermarcas will post 0.53 earnings per share for the current year.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy”.

Hypermarcas Company Profile

Hypermarcas SA was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.

The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines.